Table 2 Safety Outcomes for Each Visit by Group.

From: A Four Month Randomized Controlled Trial on the Efficacy of Once-daily Fenofibrate Monotherapy in Persons with Spinal Cord Injury

 

Normal Range

Baseline

Month 1

Month 2

Month 3

Month 4

Control

Treatment

Control

Treatment

Control

Treatment

Control

Treatment

Control

Treatment

n

 

8

10

8

10

8

10

8

10

8

10

eGFR

>59

126 (107, 144)

121 (106, 135)

125 (105, 144)

117 (103, 130)

124 (97, 150)

114 (103, 124)

127 (95, 159)

112 (101, 120)

121 (89, 153)

115 (100, 131)

ALT

0–32 IU/L

21 (15, 28)

21 (17, 26)

24 (10, 38)

37 (13, 60)

23 (12, 32)

35 (20, 50)

19 (11, 28)

33 (19, 46)

21 (14, 27)

32 (19, 45)

AST

0–40 IU/L

20 (15, 25)

22 (19, 25)

22 (11, 33)

27 (19, 36)

23 (9, 36)

29 (19, 40)

20 (13, 28)

25 (20, 30)

18 (13, 23)

28 (21, 36)

GGT

0–60 IU/L

27 (16, 37)

27 (17, 36)

24 (14, 34)

40 (17, 80)

25 (17, 33)

31 (12, 51)

24 (15, 33)

33 (19, 48)

25 (12, 39)

22 (14, 30)

RBC

3.77–5.28 g/dL

4.7 (4.3, 5.1)

4.8 (4.3, 5.1)

4.8 (4.2, 5.3)

4.7 (4.4, 5.1)

4.8 (4.3, 5.2)

4.6 (4.3, 5.0)

4.7 (4.2, 5.2)

4.6, (4.3, 5.0)

4.9 (4.4, 5.4)

4.5 (4.2, 4.8)

WBC

3.4–10.8 × 10e3/uL

6.3 (4.6, 7.9)

6.5 (5.4, 7.7)

6.5 (5.4, 7.7)

6.2 (5.0, 7.4)

6.9 (3.2, 10.5)

6.8 (5.0, 8.6)

6.3 (2.7, 10.0)

6.3 (4.7, 7.8)

7.1 (3.5, 10.7)

6.0 (4.2, 7.7)

MCV

79–97 fL

90 (86, 94)

86 (82, 90)

90 (87, 92)

87 (84, 90)

90 (87, 93)

87 (84, 89)

90 (87, 93)

87 (84, 90)

90 (87, 93)

87 (84, 89)

MCH

26.6–33.0 pg

30.4 (29.1, 31.6)

29.3 (28.2, 30.6)

30.4 (30.0, 31.2)

29.2 (28.0, 30.4)

30.2 (29.3, 31.0)

29.1 (28.0, 29.8)

30.5 (29.5, 31.5)

28.9 (28.0, 29.8)

30.2 (29.2, 31.1)

29.3 (28.4, 30.2)

MCHC

31.5–35.7 g/dL

33.8 (33.2, 34.4)

34.3 (33.7, 34.9)

33.9 (33.3, 34.5)

33.6 (33.2, 34.0)

33.5 (33.2, 33.9)

30.6 (23.7, 37.4)

33.9 (33.1, 34.7)

32.8 (31.7, 33.9)

33.5 (33.1, 34.0)

33.8 (33.2, 34.3)

RDW

12.3–15.4%

13.8 (13.2, 14.4)

14.3 (13.8, 14.8)

13.8 (13.0, 14.5)

13.8 (13.0, 14.5)

13.8 (13.0, 14.5)

14.5 (13.8, 15.0)

13.9 (13.3, 14.5)

14.3 (13.8, 15.0)

13.9 (13.4, 14.3)

14.8 (14.0, 15.5)

  1. Data are expressed as group mean ± 95% CI, unless otherwise indicated. eGFR: estimated glomerular filtration rate; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase; RBC: red blood cell; WBC: white blood cell; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW; red cell distribution width.
Back to article page